Platelets in Fetal Growth Restriction: Role of Reactive Oxygen Species, Oxygen Metabolism, and Aggregation.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
18 02 2022
Historique:
received: 07 02 2022
revised: 15 02 2022
accepted: 17 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 9 4 2022
Statut: epublish

Résumé

Fetal growth restriction (FGR) is mainly caused by failure of the uteroplacental unit. The exact pathogenesis remains unclear. The cause is thought to be related to abnormal platelet activation, which may result in microthrombus formation in the small vessels of the placenta. Reactive oxygen species (ROS) may initiate the pathological process of platelet activation. This study aimed to evaluate selected platelet parameters in pregnancy complicated by FGR and relate them to the severity of hemodynamic abnormalities. A total of 135 women (pregnant with FGR, with an uncomplicated pregnancy, and non-pregnant) were enrolled to study different platelet parameters: count (PLT), mean volume (MPV), ROS levels, intracellular oxygen level, oxygen consumption, and aggregation indices. No abnormalities in PLT and MPV were found in the FGR group, although it revealed increased ROS levels in platelets, lower platelet oxygen consumption, and intraplatelet deprivation. Aggregation parameters were similar as in uncomplicated pregnancy. No significant relationships were observed between hemodynamic abnormalities and the studied parameters. Platelets in pregnancies complicated by FGR may reveal an impaired oxidative metabolism, which may, in turn, lead to oxidative stress and, consequently, to an impaired platelet function. This study adds to the understanding of the role of platelets in the etiology of FGR.

Identifiants

pubmed: 35203373
pii: cells11040724
doi: 10.3390/cells11040724
pmc: PMC8870240
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Obstet Gynecol. 1995 Oct;173(4):1049-57
pubmed: 7485292
Am J Obstet Gynecol. 2018 Feb;218(2S):S745-S761
pubmed: 29422210
Br J Obstet Gynaecol. 1986 Oct;93(10):1049-59
pubmed: 3790464
Platelets. 2010;21(6):496-7
pubmed: 20482246
Methods. 2016 Oct 15;109:3-11
pubmed: 27302663
ACS Nano. 2011 Jul 26;5(7):5499-508
pubmed: 21671589
Obstet Gynecol. 2010 Aug;116(2 Pt 1):402-414
pubmed: 20664402
Br J Obstet Gynaecol. 1977 Sep;84(9):656-63
pubmed: 911717
J Biochem Biophys Methods. 2005 Dec 31;65(2-3):45-80
pubmed: 16297980
Science. 1988 Sep 23;241(4873):1649-51
pubmed: 3420417
Nat Protoc. 2006;1(6):2563-72
pubmed: 17406510
Compr Physiol. 2015 Jul 1;5(3):1265-80
pubmed: 26140718
Zebrafish. 2020 Aug;17(4):268-270
pubmed: 32364833
Br J Obstet Gynaecol. 1993 Jul;100(7):684-8
pubmed: 8369255
Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):287-99
pubmed: 21130690
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:144-150
pubmed: 29304392
Diabetes. 2001 Jun;50(6):1491-4
pubmed: 11375352
MethodsX. 2018 Dec 26;6:63-70
pubmed: 30619728
Platelets. 2019;30(4):438-444
pubmed: 30010456
Ultrasound Obstet Gynecol. 2016 Sep;48(3):333-9
pubmed: 26909664
Blood. 2002 Aug 1;100(3):917-24
pubmed: 12130503
Pediatr Res. 2015 Oct;78(4):457-61
pubmed: 26086641
Fetal Diagn Ther. 2014;36(2):86-98
pubmed: 24457811
Nutrients. 2020 Sep 16;12(9):
pubmed: 32948020
Am J Hum Biol. 2007 Sep-Oct;19(5):622-30
pubmed: 17636527
Front Cardiovasc Med. 2019 Oct 29;6:153
pubmed: 31737646
Platelets. 2010;21(8):587-95
pubmed: 20873962
BMJ. 2013 Jan 24;346:f108
pubmed: 23349424
Eur J Obstet Gynecol Reprod Biol. 2003 Sep 22;110 Suppl 1:S99-107
pubmed: 12965097
J Obstet Gynaecol Res. 2014 Jul;40(7):1840-5
pubmed: 25056460
Diabetes. 2013 Apr;62(4):1041-53
pubmed: 23520284
Anal Biochem. 2015 Jan 1;468:1-3
pubmed: 25233002
Br J Obstet Gynaecol. 1985 Jan;92(1):31-8
pubmed: 3966988
Antioxid Redox Signal. 2014 Jan 10;20(2):372-82
pubmed: 22978713
Methods Mol Biol. 2010;591:257-73
pubmed: 19957136
Br J Obstet Gynaecol. 1981 Jul;88(7):695-705
pubmed: 7248226
Br J Obstet Gynaecol. 1994 Mar;101(3):209-14
pubmed: 8193094
Vascul Pharmacol. 2017 Aug;93-95:6-13
pubmed: 28684282
Am J Obstet Gynecol. 2020 Nov;223(5):741.e1-741.e12
pubmed: 32434001
Circulation. 1997 Feb 18;95(4):885-91
pubmed: 9054746
Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):1988-96
pubmed: 15374851
Toxicol Sci. 2006 Jul;92(1):186-200
pubmed: 16638925
J Epidemiol Community Health. 1989 Sep;43(3):237-40
pubmed: 2607302
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):187-92
pubmed: 14604832
Pediatr Clin North Am. 2019 Apr;66(2):403-423
pubmed: 30819345
Platelets. 2002 May;13(3):175-82
pubmed: 12180500
Am J Physiol Regul Integr Comp Physiol. 2007 Apr;292(4):R1613-20
pubmed: 17170232
Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1698-706
pubmed: 9812907
Anal Chem. 2012 Mar 20;84(6):2930-8
pubmed: 22380020
Placenta. 2018 Sep;69:153-161
pubmed: 29622278
Obstet Gynecol. 2019 Feb;133(2):e97-e109
pubmed: 30681542
Reprod Toxicol. 2018 Mar;76:46-52
pubmed: 29277664
Hypertens Pregnancy. 2007;26(1):39-50
pubmed: 17454217
J Lab Clin Med. 1992 Apr;119(4):364-70
pubmed: 1583386
Placenta. 1999 Sep;20(7):555-60
pubmed: 10452909
J Interferon Cytokine Res. 2002 Sep;22(9):913-22
pubmed: 12396713

Auteurs

Joanna Nowaczyk (J)

Department of Perinatology and Gynecology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.

Barbara Poniedziałek (B)

Department of Environmental Medicine, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Piotr Rzymski (P)

Department of Environmental Medicine, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), 60-806 Poznań, Poland.

Dominika Sikora (D)

Department of Environmental Medicine, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

Mariola Ropacka-Lesiak (M)

Department of Perinatology and Gynecology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH